caffeine has been researched along with Nervous System Disorders in 14 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Growth, neurologic, and ophthalmologic assessments were done in 21 low-birth-weight infants given caffeine for neonatal apnea and in 21 matched control infants." | 7.66 | Sequelae of caffeine treatment in preterm infants with apnea. ( Aranda, JV; Gunn, TR; Metrakos, K; Riley, P; Willis, D, 1979) |
| "Numerous case reports have documented that phenylpropanolamine (PPA) stimulates the central nervous system with symptoms ranging from anxiety and hallucinations to grand mal seizures produced by overdoses." | 3.67 | Phenylpropanolamine potentiates caffeine neurotoxicity in rats. ( Walker, JS, 1989) |
| "Theophylline can cause life-threatening seizures when administered in excessive doses." | 3.67 | Caffeine as a potential risk factor for theophylline neurotoxicity. ( Levy, G; Yasuhara, M, 1988) |
| "Growth, neurologic, and ophthalmologic assessments were done in 21 low-birth-weight infants given caffeine for neonatal apnea and in 21 matched control infants." | 3.66 | Sequelae of caffeine treatment in preterm infants with apnea. ( Aranda, JV; Gunn, TR; Metrakos, K; Riley, P; Willis, D, 1979) |
| "Higher EEG theta activity related to sleep deprivation was observed in mutated TNF-α, PER3, and COMT carriers, in the placebo condition particularly." | 3.01 | Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882). ( Bourrilhon, C; Chennaoui, M; Drogou, C; Erblang, M; Erkel, MC; Gomez-Merino, D; Guillard, M; Léger, D; Quiquempoix, M; Rabat, A; Sauvet, F; Thomas, C; Trignol, A; Van Beers, P, 2021) |
| " Recent and significant literature describing adverse events associated with energy drink use are reviewed." | 2.48 | Toxicity of energy drinks. ( Babu, KM; Ganetsky, M; Wolk, BJ, 2012) |
| "Caffeine is a plant-derived psychostimulant and a common additive found in a wide range of foods and pharmaceuticals." | 1.43 | Quantitative Proteomic Analysis of the Orbital Frontal Cortex in Rats Following Extended Exposure to Caffeine Reveals Extensive Changes to Protein Expression: Implications for Neurological Disease. ( Cornish, JL; Franklin, JL; Goodchild, AK; Haynes, PA; Homewood, J; Mirzaei, M; Wearne, TA, 2016) |
| "Caffeine is a receptor antagonist for adenosine that might interfere with the neuroprotective effect of adenosine in ischemic-hypoxic conditions." | 1.32 | Caffeine impairs short-term neurological outcome after concussive head injury in rats. ( Ahmad Khan, H; Al Deeb, S; Al Moutaery, K; Tariq, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Jee, HJ | 1 |
| Lee, SG | 1 |
| Bormate, KJ | 1 |
| Jung, YS | 1 |
| Erblang, M | 1 |
| Sauvet, F | 1 |
| Drogou, C | 1 |
| Quiquempoix, M | 1 |
| Van Beers, P | 1 |
| Guillard, M | 1 |
| Rabat, A | 1 |
| Trignol, A | 1 |
| Bourrilhon, C | 1 |
| Erkel, MC | 1 |
| Léger, D | 1 |
| Thomas, C | 1 |
| Gomez-Merino, D | 1 |
| Chennaoui, M | 1 |
| Franklin, JL | 1 |
| Mirzaei, M | 1 |
| Wearne, TA | 1 |
| Homewood, J | 1 |
| Goodchild, AK | 1 |
| Haynes, PA | 1 |
| Cornish, JL | 1 |
| Ribeiro, JA | 1 |
| Sebastião, AM | 1 |
| Wolk, BJ | 1 |
| Ganetsky, M | 1 |
| Babu, KM | 1 |
| Al Moutaery, K | 1 |
| Al Deeb, S | 1 |
| Ahmad Khan, H | 1 |
| Tariq, M | 1 |
| HABER, H | 1 |
| MATTHIES, H | 1 |
| ERDMANN, D | 1 |
| Buhr, G | 1 |
| Gunn, TR | 1 |
| Metrakos, K | 1 |
| Riley, P | 1 |
| Willis, D | 1 |
| Aranda, JV | 1 |
| Panikarskiĭ, VG | 1 |
| Tanaka, M | 1 |
| Takeuchi, T | 1 |
| Yagishita, S | 1 |
| Inoue, T | 1 |
| Walker, JS | 1 |
| Yasuhara, M | 1 |
| Levy, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Polymorphisms and Efficiency of Caffeine on Performances During Total Sleep Deprivation un Healthy Subject. Multicentric, Versus Placebo, Randomised, Cross Over, Double Blind Study[NCT03859882] | 52 participants (Actual) | Interventional | 2018-09-02 | Completed | |||
| The Impact of Caffeine on Cognition in Schizophrenia[NCT02832401] | 24 participants (Actual) | Interventional | 2016-09-02 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for caffeine and Nervous System Disorders
| Article | Year |
|---|---|
Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Caffeine; Dose-Response Relationship, Drug; | 2020 |
Caffeine and adenosine.
Topics: Adenosine; Animals; Caffeine; Cognition; Humans; Learning; Mental Disorders; Models, Biological; Ner | 2010 |
Toxicity of energy drinks.
Topics: Adolescent; Caffeine; Cardiovascular Diseases; Child; Drug Interactions; Energy Drinks; Ethanol; Hum | 2012 |
1 trial available for caffeine and Nervous System Disorders
| Article | Year |
|---|---|
Genetic Determinants of Neurobehavioral Responses to Caffeine Administration during Sleep Deprivation: A Randomized, Cross Over Study (NCT03859882).
Topics: Adult; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Female; | 2021 |
10 other studies available for caffeine and Nervous System Disorders
| Article | Year |
|---|---|
Quantitative Proteomic Analysis of the Orbital Frontal Cortex in Rats Following Extended Exposure to Caffeine Reveals Extensive Changes to Protein Expression: Implications for Neurological Disease.
Topics: Animals; Caffeine; Cell Communication; Cytoskeleton; Gene Expression Profiling; Gene Expression Regu | 2016 |
Caffeine impairs short-term neurological outcome after concussive head injury in rats.
Topics: Animals; Blood-Brain Barrier; Brain Concussion; Caffeine; Central Nervous System Stimulants; Disease | 2003 |
[Thoughts and questions on neural therapy with impletol].
Topics: Caffeine; Drug Combinations; Humans; Nervous System Diseases; Procaine | 1953 |
[Effect of caffeine on the conditioned reflex in rat & on experimental nervous system disorder].
Topics: Animals; Caffeine; Conditioning, Classical; Nervous System Diseases; Rats; Reflex | 1957 |
[On the effect of caffeine on the peripheral circulation and its neural regulation].
Topics: Arteriosclerosis; Blood Circulation; Caffeine; Coronary Disease; Humans; Hypertension; Nervous Syste | 1966 |
Sequelae of caffeine treatment in preterm infants with apnea.
Topics: Apnea; Caffeine; Child Development; Female; Follow-Up Studies; Humans; Infant, Low Birth Weight; Inf | 1979 |
[Problems in treatment of autonomic disorders accompanying hypertensive disease].
Topics: Adult; Autonomic Nervous System; Benzimidazoles; Caffeine; Calcium; Female; Gluconates; Humans; Hype | 1977 |
[A case of intoxication with thinner, Bond and Optalidon, showing various psychiatric symptoms and polyneuropathy].
Topics: Adult; Aminopyrine; Barbiturates; Caffeine; Drug Combinations; Humans; Male; Muscles; Nervous System | 1975 |
Phenylpropanolamine potentiates caffeine neurotoxicity in rats.
Topics: Animals; Appetite Depressants; Blood Proteins; Caffeine; Chromatography, High Pressure Liquid; Drug | 1989 |
Caffeine as a potential risk factor for theophylline neurotoxicity.
Topics: Animals; Blood Proteins; Brain; Caffeine; Dialysis; Injections, Intravenous; Male; Nervous System Di | 1988 |